PGNY · Company research
Progyny, Inc. Common Stock (PGNY): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 27.55 | $2,130,318,901.92 | 1977686901.92 | 75.0588235294117647 | — | 0.95074509803921570521 | 6.0777519162594041 | 4.7000242730283261 | 48.19071849794145591122 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.